 The FDA has granted emergency use authorization for Cue Healths rapid Covid test, making it the first molecular test for Covid-19 authorized for at-home use without a prescription. Ayub Khattak, Cue Health co-founder and CEO, joined Squawk Box on Monday to discuss. 